Patented and cleared by the FDA in 2021, Amma is the world’s first patient administered scalp-cooling solution. Based on current reimbursement available, Cooler Heads provides the Amma platform directly to infusion centers, giving patients access to this scalp cooling solution throughout their chemotherapy regimen.  Our objective is to make this option available at every infusion center across the country.

Cooler Heads transforms life for people diagnosed with cancer by giving them more control over how they experience the side effects of treatment. Cooler Heads’ debut product is Amma, an affordable and transportable scalp-cooling system that democratizes the innovative therapy. Amma™ gives people with cancer a choice in whether they lose their hair during chemotherapy. This impacts more than how they look; it impacts their entire sense of self, and it can improve their mental health and their recovery.

By partnering directly with Cooler Heads, healthcare providers can now provide the Amma technology straight to the patients they serve. For patients, this means having easier access to scalp cooling from those intimately invested in your day-to-day care.